The clinical question
This program is driven by the clinical goal of preserving tissue and function in severe lower-limb ischemia. Development focuses on measurable changes in perfusion, wound healing and limb function.
Our research approach
mRNA engineering is used to enhance the functional payload of MSCs. VEGFA-based designs are being evaluated; final payload composition and product configuration are defined at the individual study level.
Current development focus
Work spans preclinical development, process definition and exploratory-study preparation. Related research and filing preparations do not imply approval, enrollment or established clinical benefit for every VEGFA-based product configuration.
Questions that guide development
- What expression profile supports the intended local vascular response?
- How should perfusion, wound healing and function be measured together?
- Which final product configuration and manufacturing controls support a clinical study?
This is an investigational research program. No clinical efficacy, completed clinical filing or commercial authorization is implied.